As of January 23, 2025, Dare Bioscience (DARE) has a market cap of $28.537 million USD. According to our data, Dare Bioscience is ranked No.8434 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $28.54 M |
5.13%
|
Dec 31, 2024 | $27.15 M |
-15.86%
|
Dec 29, 2023 | $32.26 M |
-62.77%
|
Dec 30, 2022 | $86.66 M |
-58.50%
|
Dec 31, 2021 | $0.21 B |
49.25%
|
Dec 31, 2020 | $0.14 B |
63.41%
|
Dec 31, 2019 | $85.61 M |
15.33%
|
Dec 31, 2018 | $74.23 M |
-67.14%
|
Dec 29, 2017 | $0.23 B |
-69.44%
|
Dec 30, 2016 | $0.74 B |
-74.71%
|
Dec 31, 2015 | $2.92 B |
-54.98%
|
Dec 31, 2014 | $6.49 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Evofem Biosciences
EVFM
|
$1.00 M |
0.000 M
|
USA
|
Agile Therapeutics
AGRX
|
$10.43 M |
0.000 M
|
USA
|
TherapeuticsMD
TXMD
|
$11.99 M |
0.000 M
|
USA
|
Femasys
FEMY
|
$26.10 M |
0.000 M
|
USA
|
Veru
VERU
|
$0.15 B |
0.000 M
|
USA
|
Amarin Corporation
AMRN
|
$0.22 B |
0.000 M
|
Ireland
|
Radius Recycling (Schnitzer Steel)
RDUS
|
$0.37 B |
2.600 M
|
USA
|
Market Cap | = | DARE Stock Price | * | DARE Shares Outstanding |
= | $3.28 | * | 8.70 M | |
= | $28.54 M |